SC 13G Filing

Company

TScan Therapeutics, Inc.

Filed

April 29, 2024

Accession Number

0000929638-24-001648

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →